TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ELDN

Eledon Pharmaceuticals Inc

Healthcare · Biotechnology

2.70$ -5.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ELDN
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00
– – 0.00 0.04 0.01 0.00 0.00 0.02 0.01 0.01 0.03 0.02 0.01 –
– – 0.00 -0.04 -0.01 0.00 0.00 -0.02 -0.01 0.01 -0.03 -0.02 -0.01 –
2.91 4.81 20.28 13.06 6.02 0.43 0.76 0.69 0.40 1.60 1.90 1.23 1.07 0.81
0.90 1.40 12.36 5.05 3.15 2.37 0.80 0.51 0.66 0.89 0.89 0.52 0.38 0.21
3.81 6.21 32.64 18.12 9.18 2.81 1.56 1.19 1.22 2.49 6.19 1.73 1.45 1.02
-3.81 -6.21 -32.64 -18.12 -9.18 -2.81 -1.56 -1.20 -1.22 -2.49 -6.19 -1.75 -1.45 -1.02
0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.00 0.64 0.01 0.03 – – –
-3.81 -6.20 -32.41 -18.05 -9.14 -2.80 -1.56 -1.36 -1.53 -2.49 -6.16 -1.64 -0.74 -0.56
– – -0.26 – 0.03 – 0.00 0.16 -0.03 -0.16 -0.03 – 0.01 0.00
-3.81 -6.20 -32.41 -18.05 -9.14 -2.80 -1.56 -1.36 -1.50 -2.33 -6.16 -1.64 -0.75 -0.56
-3.80 -6.20 -32.38 -18.00 -1.66 -2.80 -1.56 -1.34 -1.06 -2.47 -2.76 -1.73 -0.73 -0.55

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?